Regnard J F, Grunenwald D, Spaggiari L, Girard P, Elias D, Ducreux M, Baldeyrou P, Levasseur P
Department of Thoracic Surgery, Marie Lannelongue Hospital, Institut Mutualiste Montsouris, Paris, France.
Ann Thorac Surg. 1998 Jul;66(1):214-8; discussion 218-9. doi: 10.1016/s0003-4975(98)00269-0.
Selected patients with double hepatic and pulmonary metastases from colorectal cancer may benefit from operation.
From 1970 to 1995, 239 patients underwent operation for resection of pulmonary metastases from colorectal cancer at two French surgical centers. Among these patients, 43 (18%) had previously undergone complete resection of hepatic metastases and constitute the subject of this retrospective study.
The median interval time between hepatic and pulmonary resections was 18 months. Two pneumonectomies, 5 lobectomies, 3 segmentectomies, 6 wedge resections, and 27 metastasectomies were performed. No postoperative mortality was observed. Two patients had major postoperative complications. Seven patients (16%) underwent subsequent pulmonary resection for recurrences. Twenty-one patients were still alive, 14 free of disease. The median survival from pulmonary resection was 19 months and the 5-year probability of survival was 11%. Prethoracotomy carcinoembryonic antigen blood levels and the number of pulmonary resection were found to be significant prognostic factors; the interval time between hepatic and pulmonary resection (> 36 months) was borderline significant (p = 0.06).
Selected patients with combined hepatic and pulmonary metastases from colorectal cancer should be considered for surgical resection. Patients with normal prethoracotomy carcinoembryonic antigen levels and late metachronous pulmonary metastasis, appear to be the best surgical candidates.
部分患有结直肠癌肝肺双转移的患者可能从手术中获益。
1970年至1995年,在法国的两个外科中心,239例患者接受了手术切除结直肠癌肺转移灶。在这些患者中,43例(18%)此前已接受肝转移灶的完整切除,构成本回顾性研究的对象。
肝切除与肺切除之间的中位间隔时间为18个月。实施了2例全肺切除术、5例肺叶切除术、3例肺段切除术、6例楔形切除术和27例转移灶切除术。未观察到术后死亡病例。2例患者出现严重术后并发症。7例患者(16%)因复发接受了后续肺切除术。21例患者仍存活,14例无疾病。肺切除术后的中位生存期为19个月,5年生存率为11%。开胸术前癌胚抗原血水平和肺切除次数被发现是显著的预后因素;肝切除与肺切除之间的间隔时间(>36个月)临界显著(p = 0.06)。
部分患有结直肠癌肝肺联合转移的患者应考虑手术切除。开胸术前癌胚抗原水平正常且出现晚期异时性肺转移的患者似乎是最佳手术候选者。